ATXS vs TDG · rev $706.0K vs P/E 41, rev $8.83B
Astria Therapeutics Inc (ATXS) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ATXS currently screens at market cap $382.1M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ATXS and TDG stock pages for the full models.
Not investment advice.